JPMorgan Chase & Co’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $980K | Sell |
457,919
-586,222
| -56% | -$1.25M | ﹤0.01% | 3741 |
|
|
2025
Q1 | $1.2M | Buy |
1,044,141
+115,552
| +12% | +$133K | ﹤0.01% | 3560 |
|
|
2024
Q4 | $2.03M | Sell |
928,589
-78,930
| -8% | -$173K | ﹤0.01% | 3395 |
|
|
2024
Q3 | $2.2M | Buy |
1,007,519
+20,236
| +2% | +$44.1K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $2.28M | Buy |
987,283
+33,810
| +4% | +$78.1K | ﹤0.01% | 3006 |
|
|
2024
Q1 | $5.24M | Buy |
953,473
+843,101
| +764% | +$4.64M | ﹤0.01% | 2544 |
|
|
2023
Q4 | $273K | Sell |
110,372
-49,059
| -31% | -$121K | ﹤0.01% | 4239 |
|
|
2023
Q3 | $5.54M | Sell |
159,431
-24,111
| -13% | -$837K | ﹤0.01% | 2359 |
|
|
2023
Q2 | $6.02M | Sell |
183,542
-50,108
| -21% | -$1.64M | ﹤0.01% | 2370 |
|
|
2023
Q1 | $7.83M | Buy |
233,650
+216,697
| +1,278% | +$7.26M | ﹤0.01% | 2171 |
|
|
2022
Q4 | $556K | Buy |
16,953
+4,705
| +38% | +$154K | ﹤0.01% | 3694 |
|
|
2022
Q3 | $428K | Buy |
12,248
+264
| +2% | +$9.23K | ﹤0.01% | 3834 |
|
|
2022
Q2 | $147K | Buy |
11,984
+4,391
| +58% | +$53.9K | ﹤0.01% | 4458 |
|
|
2022
Q1 | $103K | Sell |
7,593
-55,717
| -88% | -$756K | ﹤0.01% | 4733 |
|
|
2021
Q4 | $1.26M | Buy |
+63,310
| New | +$1.26M | ﹤0.01% | 3531 |
|